Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical efficacy of relevant PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. حسب Filip Stanicic (17808254)

الموضوعات:

Patient demographics. حسب Katrine Carlsen (5477300)

الموضوعات:

Alpha diversity measures across all 727 samples. حسب Katrine Carlsen (5477300)

الموضوعات:

STORMS microbiome reporting checklist. حسب Katrine Carlsen (5477300)

الموضوعات:

Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. حسب Vincenza Tarantino (182506)

Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- حسب So-Hyeon Bok (8066696)

Forest plots illustrate the mean difference in; (A) creatinine clearance, (B) eGFR, (C) BUN, and (D) shows relative risk in ARF. حسب Mohamed R. Abdelraouf (21501468)

Means scores of CAM and CAM-MYCS. حسب Senay Yildirim-Kahriman (22693464)

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. حسب Farrokh Habibzadeh (12256529)

No significant diurnal rhythmicity of short chain fatty acids in the blood was observed. حسب Weiran Shan (16969688)

Recruitment flow diagram of the current study. حسب Somayeh Momenyan (10111603)

"…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …"

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance حسب Yifan Liu (219681)

الموضوعات: